Drug Profile
Research programme: ALK gene diagnostics - Cell Signalling Technology/Cepheid
Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Cell Signaling Technology
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Non-small cell lung cancer
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Non-small-cell-lung-cancer(Diagnosis) in USA
- 31 Jul 2013 Early research in Non-small cell lung cancer in USA (unspecified route)